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FIG. 1 RT-PCR analysis of myosin VIIA expression In human 
mouse ( b )  tissues, a, A 402-bp specific product 
(lane 2 ) ,
A 407-bp product is detected In retina (lane 1), cochlea (lane I)
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base ladder (BRL).
Total RNA was
f. s ■ ^  '///s ■ \  ' > ■> ',y  ' ' i
'-m m , 




- ' ê f :










»IS!'.*/ ■ ■. '
'< ■ ■ < ..'/r,
u-. ;
■''Z
■ !  V /' ' ' "  .-Ív-'V 
'ó >i
W',
L E T T E R S  T U  N A T O  SIE
respectively substitute a cysteine and a histidine codon for the 
same arginine codon. None of these mutations was found in the 
74 alleles from the general population that were sequenced as 
controls.
The identification of the mutations in both alleles of the 
affected children from family 1, and the cosegregation of each 
of these mutations with the disease, provide strong evidence that 
the myosin VIIA gene is responsible for USH IB. Moreover, the 
nonsense mutations found in exons 1 and 3 would result in 
proteins truncated before the ATP-binding site and the actin- 
binding site respectively and therefore not functional. The isoleu­
cine present in the two-amino-acid deletion is a highly conserved 
residue in conventional (myosin II) as well as unconventional 
myosins (Fig. 3). These two residues are located inside a large 
/7-sheet17 and hence are likely to result in an incorrect folding 
of the motor domain and consequently in an inactive protein. 
The two substitutions of the arginine present in a highly conser­
ved heptapeptide sequence (Fig. 3) close to the phosphate- 
binding site17 would also be expected to impair the function of 
this myosin.
Our results and those described in the accompanying Letter 
establish that USH1B  and shaker-1 involve the orthologous 
myosin VIIA genes. But the phenotypes of the original ahl mut­
ant and of the live other shl mutants seem to be different from 
that of USHI patients, because no sign of retinal degeneration 
has so far been reported in these mouse mutants18,19. Therefore 
either another myosin could compensate for a defective myosin 
VIIA in the mouse retina or the nature of the mutation itself14 
might account for the phenotypic difference. One form of human 
ncurosensorial recessive deafness without retinal dystrophy, 
attributed to the gene DFNB2, which maps to the same chromo-
a
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FIG. 3 Amino-acid alignments in different myosins around the missense 
mutations and the 2-amino-acid deletion. The heptapeptide sequences 
containing the mutated arginine and the deleted isoleucine are indica­
ted in bold.
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somal region as USH1B, may represent the human equivalent 
of the sh-1 mutants15.
Unconventional myosins are motor molecules with structur­
ally conserved heads, which move along actin filaments using 
their actin-activated ATPase activity, Their highly divergent tails 
are presumed to be tethered to different macromolecular struc­
tures that move relative to actin filaments20,21. If we assume that 
the anomalous connecting cilium of photoreceptor cells 
described in some USH patients is associated with clinical sub- 
type 1B, we have to postulate an interaction between actin fila­
ments and micro tubules involving myosin VIIA. The presence 
of myosin at the base of connecting cilia22 is consistent with 
this postulate. According to this hypothesis, the kinocilium of 
cochlear and vestibular hair cells could be the primary defective 
structure in the inner ear23; However, such an interaction 
between microfilaments and the microtubule network is still 
poorly documented24,25, Alternatively, in the absence of direct 
evidence for abnormal microtubular structures in USH IB, a role 
for myosin VIIA is a possibility in the microvilli of the retinal 
pigment cells, the inner-ear supporting cells and in the hair­
cell stereocilia. Such a role is consistent with the presence of 
unconventional myosins in intestinal cell microvilli26 and at the 
tip of the hair-cell stereocilia, where one or several myosins are 
presumably responsible for modulating the tip-link tension that 
controls the gating of cation-transduction channels27 2t).
As there are at least seven genes responsible for Usher 
syndrome2, it is possible that abnormalities in the genes encoding 
other unconventional myosins and their various binding compo­
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FIG. 2 Nucleotide and deduced amino-acid sequences of the two 
myosin VIIA exons of the human gene containing the mutations, a, Exon 
1; b, exon 3. The mutations are indicated above and below the normal 
sequences and the 6-bp deletion which was found in two different 
families is underlined. Arrows show the 5-bp direct repeat. A silent 
polymorphism was detected in exon 1 at the third position (G —»-A) and 
in exon 3 at position 83 (C->T). The primers used for sequencing were: 
la , 5'-ACTAACTCCGAGCCAGACC-3'; lb , 5'-GTTACACAGCACAGAGTACAT~ 
AG-3'; 3a, 5'-GATTGAGCAGCAGGTCTT-3'; 3b, 5'-CAATACGGGCAGCAAT- 
AC-3'.
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